Medicine makers end the week on a high note at Dalal Street
Advertisement
Advertisement
Shares of medicine makers were mostly higher in weak trade on Friday as investors sought the safety of predictable revenue and profit streams coupled with the potential of higher-than-expected sales following the depreciation in the The Rupee fell to a fresh 2-year low versus the Dollar as a global turmoil in currencies and
As a result, 6 out of 11 pharma stock futures posted gains with rising open interest and four pharma companies hit fresh highs in an overall market that has slumped to 2-month lows.
Strides Arcolabs gained 1.8 percent to 1,343 rupees. Divi's Labs was up 1.4 percent to 2,435 rupees. Auro Pharma rose 1.6 percent to 810 rupees. Glenmark Pharma was up 13 percent to 1,231 rupees. Cipla rose 0.7 percent to 697.30 rupees. and
Torrent Pharma and Sanofi India were the other stocks that rose in the drugs space.
Advertisement
(Image credits: Indiatimes)
Advertisement
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- 2 states where home prices are falling because there are too many houses and not enough buyers
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- 9 health benefits of drinking sugarcane juice in summer
- 10 benefits of incorporating almond oil into your daily diet
- From heart health to detoxification: 10 reasons to eat beetroot
- Why did a NASA spacecraft suddenly start talking gibberish after more than 45 years of operation? What fixed it?
- ICICI Bank shares climb nearly 5% after Q4 earnings; mcap soars by ₹36,555.4 crore